Polpharma Biologics Group Announces that the Biologics License Application (BLA) Submitted by its Joint Venture Bioeq for its Biosimilar Ranibizumab has Been Accepted for ...

FDA file acceptance for Bioeq`s ranibizumab biosimilar program compliments marketing authorization applications submitted to EMA & MHRA this year.

NuCana Receives Fast Track Designation from the U.S. Food and Drug Administration for Acelarin® (NUC-1031) for the Treatment of Biliary Tract Cancer

29, 2021 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ:NCNA) announced that the U.S. Food and Drug Administration (FDA ... the development and expedite the review of drugs to treat serious conditions ...

PsyBio Therapeutics Announces Pre-IND Application Request Has Been Submitted to the United States Food and Drug Administration

OXFORD, Ohio and COCONUT CREEK, Fla., Sept. 23, 2021 /CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"), an intellectual property driven biotechnology company ...